ClinicalTrials.Veeva

Menu

Effects of Plant Based Lipids on Glucose Regulation and Cognitive Variables

L

Lund University

Status

Completed

Conditions

Obesity
Diabete Type 2

Treatments

Dietary Supplement: lipids

Study type

Interventional

Funder types

Other

Identifiers

NCT05276128
2018/658

Details and patient eligibility

About

The overall goal is to increase the knowledge that can be used for the development of food products with anti-diabetic properties, with the purpose to facilitate healthier food choices for people. More specifically the primary purpose of this project is to evaluate effects in healthy humans on acute postprandial glucose regulation of plant based lipids. Due to the tight connection between cardiometabolic health and cognitive functions, a secondary issue is to investigate effects of test foods on cognitive test variables and mood parameters.

Enrollment

17 patients

Sex

All

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Apparently healthy subjects
  • Between 20 and 40 years old
  • Body mass index between 19-28 kg / m2),
  • Consuming a non-vegetarian diet generally in line with the Nordic nutrition recommendations.

Exclusion criteria

  • Fasting blood glucose concentration >6.1 mmol/L
  • Known metabolic or gastrointestinal disorder (eg diabetes, high cholesterol, high blood pressure, IBS), or other disease that may affect the study results.
  • Regular medication, except for long-term and stable medication for the lack or reduced production of thyroid hormone (eg Levaxin).
  • Antibiotics or probiotics for at least four weeks before the start of the study,
  • The use of tobacco products

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

17 participants in 5 patient groups

WWB Reference
Other group
Description:
White wheat bread (WWB) without lipid supplements. The effects of this high glycaemic product on postprandial glucose and insulin responses are well studied.
Treatment:
Dietary Supplement: lipids
WWB 5g active lipids
Experimental group
Description:
WWB supplemented with 5 g active lipids, and 10 g control lipids
Treatment:
Dietary Supplement: lipids
WWB 10g active lipids
Experimental group
Description:
WWB supplemented with 10g active lipids, and 5 g control lipids
Treatment:
Dietary Supplement: lipids
WWB 15g active lipids
Experimental group
Description:
WWB supplemented with 15g active lipids, and 0 g control lipids
Treatment:
Dietary Supplement: lipids
WWB 15 g control lipids
Active Comparator group
Description:
WWB supplemented with 15g control lipids
Treatment:
Dietary Supplement: lipids

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems